• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷霉素对革兰氏阴性尿路病原体的体外活性及磷霉素耐药的生物学代价。

In vitro activity of fosfomycin against gram-negative urinary pathogens and the biological cost of fosfomycin resistance.

作者信息

Marchese Anna, Gualco Laura, Debbia Eugenio A, Schito Gian Carlo, Schito Anna Maria

机构信息

Sezione di Microbiologia, Di.S.C.A.T., University of Genoa, Genoa, Italy.

出版信息

Int J Antimicrob Agents. 2003 Oct;22 Suppl 2:53-9. doi: 10.1016/s0924-8579(03)00230-9.

DOI:10.1016/s0924-8579(03)00230-9
PMID:14527772
Abstract

The aim of this study was to reassess the activity of fosfomycin against recently isolated uropathogens circulating in Italy and to evaluate the effect of fosfomycin resistance on the expression of several virulence traits using the rare mutant strains. In vitro activity of fosfomycin was evaluated using 441 Gram-negative organisms isolated from patients with uncomplicated urinary tract infections (UTIs). Fosfomycin was the most active antibiotic against Escherichia coli (99% susceptibility). The activity against Proteus mirabilis was more potent than that of co-trimoxazole and nitrofurantoin (87.5, 67 and 0% susceptibility, respectively). The other microorganisms, accounting for about 7% of all pathogens tested, showed variable susceptibilities to fosfomycin. Compared with susceptible strains, fosfomycin-resistant mutants showed a reduced rate of growth and were impaired in their ability to adhere to uroepithelial cells and to urinary catheters. They were also more resistant to UV irradiation and to phage T7 and showed diminished rates of colicin synthesis and transfer of plasmids.

摘要

本研究的目的是重新评估磷霉素对意大利近期分离出的尿路病原体的活性,并使用罕见突变菌株评估磷霉素耐药性对几种毒力特征表达的影响。使用从单纯性尿路感染(UTIs)患者中分离出的441株革兰氏阴性菌评估了磷霉素的体外活性。磷霉素是对大肠杆菌最具活性的抗生素(敏感性为99%)。对奇异变形杆菌的活性比对复方新诺明和呋喃妥因更强(敏感性分别为87.5%、67%和0%)。其他微生物约占所有测试病原体的7%,对磷霉素表现出不同的敏感性。与敏感菌株相比,磷霉素耐药突变体的生长速率降低,黏附于尿路上皮细胞和尿管的能力受损。它们对紫外线照射和噬菌体T7也更具抗性,并且大肠菌素合成速率和质粒转移速率降低。

相似文献

1
In vitro activity of fosfomycin against gram-negative urinary pathogens and the biological cost of fosfomycin resistance.磷霉素对革兰氏阴性尿路病原体的体外活性及磷霉素耐药的生物学代价。
Int J Antimicrob Agents. 2003 Oct;22 Suppl 2:53-9. doi: 10.1016/s0924-8579(03)00230-9.
2
Evaluation of the in vitro activity of fosfomycin tromethamine against Gram-negative bacterial strains recovered from community- and hospital-acquired urinary tract infections in Turkey.评价三甲氧氨磷霉素在土耳其社区获得性和医院获得性尿路感染分离的革兰阴性菌中的体外活性。
Int J Infect Dis. 2013 Nov;17(11):e966-70. doi: 10.1016/j.ijid.2013.04.005. Epub 2013 Jun 3.
3
An update on the management of urinary tract infections in the era of antimicrobial resistance.抗菌药物耐药时代泌尿道感染管理的最新进展
Postgrad Med. 2017 Mar;129(2):242-258. doi: 10.1080/00325481.2017.1246055. Epub 2016 Oct 21.
4
In vitro activity of fosfomycin tromethamine against extended spectrum beta-lactamase producing urinary tract bacteria.磷霉素氨丁三醇对产超广谱β-内酰胺酶尿路细菌的体外活性
J Coll Physicians Surg Pak. 2014 Dec;24(12):914-7.
5
In vitro activity of fosfomycin trometamol against pathogens from urinary tract infections: a Spanish multicenter study.磷霉素氨丁三醇对尿路感染病原体的体外活性:一项西班牙多中心研究。
J Chemother. 1997 Dec;9(6):394-402. doi: 10.1179/joc.1997.9.6.394.
6
The susceptibility to fosfomycin of Gram-negative bacteria isolates from urinary tract infection in the Czech Republic: data from a unicentric study.捷克共和国尿路感染分离出的革兰氏阴性菌对磷霉素的敏感性:一项单中心研究的数据
BMC Urol. 2017 Apr 26;17(1):33. doi: 10.1186/s12894-017-0222-6.
7
The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections.ARESC研究:一项关于单纯性尿路感染相关病原体抗菌药物耐药性的国际调查。
Int J Antimicrob Agents. 2009 Nov;34(5):407-13. doi: 10.1016/j.ijantimicag.2009.04.012. Epub 2009 Jun 7.
8
Antimicrobial susceptibility of Gram-negative nonurinary bacteria to fosfomycin and other antimicrobials.革兰氏阴性非尿细菌对磷霉素和其他抗菌药物的药敏性。
Future Microbiol. 2010 Jun;5(6):961-70. doi: 10.2217/fmb.10.47.
9
In vitro activity of prulifloxacin against Escherichia coli isolated from urinary tract infections and the biological cost of prulifloxacin resistance.普卢利沙星对从尿路感染分离出的大肠杆菌的体外活性及普卢利沙星耐药的生物学代价。
Int J Antimicrob Agents. 2007 Jun;29(6):679-87. doi: 10.1016/j.ijantimicag.2007.01.009. Epub 2007 Mar 23.
10
Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in Antananarivo, Madagascar.马达加斯加塔那那利佛地区引起社区获得性尿路感染的尿路病原菌的耐药性。
J Antimicrob Chemother. 2007 Feb;59(2):309-12. doi: 10.1093/jac/dkl466. Epub 2006 Nov 29.

引用本文的文献

1
Chromosomal genes modulating fosfomycin susceptibility in uropathogenic : a genome-wide analysis.调节尿路致病性大肠杆菌对磷霉素敏感性的染色体基因:全基因组分析
Antimicrob Agents Chemother. 2025 Apr 2;69(4):e0141724. doi: 10.1128/aac.01417-24. Epub 2025 Feb 25.
2
In Vitro Antibacterial Activities of Fosfomycin against Isolates from Canine Urinary Tract Infection.磷霉素对犬尿路感染分离株的体外抗菌活性
Animals (Basel). 2024 Jun 28;14(13):1916. doi: 10.3390/ani14131916.
3
Impact of a Primary Care Antimicrobial Stewardship Program on Bacterial Resistance Control and Ecological Imprint in Urinary Tract Infections.
基层医疗抗菌药物管理计划对尿路感染细菌耐药性控制及生态印记的影响
Antibiotics (Basel). 2022 Dec 8;11(12):1776. doi: 10.3390/antibiotics11121776.
4
Efficacy and Safety of Oral Fosfomycin-Trometamol in Male Urinary Tract Infections with Multidrug-Resistant Enterobacterales.口服磷霉素氨丁三醇治疗男性多重耐药肠杆菌科细菌所致尿路感染的疗效与安全性
Antibiotics (Basel). 2022 Feb 3;11(2):198. doi: 10.3390/antibiotics11020198.
5
Novel Chromosomal Mutations Responsible for Fosfomycin Resistance in .导致[具体对象]对磷霉素耐药的新型染色体突变
Front Microbiol. 2020 Oct 20;11:575031. doi: 10.3389/fmicb.2020.575031. eCollection 2020.
6
The Role of in Challenges with Fosfomycin Susceptibility Testing of Multispecies Klebsiella pneumoniae Carbapenemase-Producing Clinical Isolates.在多物种产碳青霉烯酶肺炎克雷伯菌临床分离株的磷霉素药敏试验挑战中 的作用。
J Clin Microbiol. 2019 Sep 24;57(10). doi: 10.1128/JCM.00634-19. Print 2019 Oct.
7
Unexpected Activity of Oral Fosfomycin against Resistant Strains of Escherichia coli in Murine Pyelonephritis.口服磷霉素对肾盂肾炎耐药大肠杆菌的意外活性。
Antimicrob Agents Chemother. 2019 Jul 25;63(8). doi: 10.1128/AAC.00903-19. Print 2019 Aug.
8
Nitrofurantoin and fosfomycin for resistant urinary tract infections: old drugs for emerging problems.用于耐药性尿路感染的呋喃妥因和磷霉素:应对新问题的老药
Aust Prescr. 2019 Feb;42(1):14-19. doi: 10.18773/austprescr.2019.002. Epub 2019 Feb 1.
9
Urinary Tract Conditions Affect Fosfomycin Activity against Escherichia coli Strains Harboring Chromosomal Mutations Involved in Fosfomycin Uptake.尿路条件影响磷霉素对携带参与磷霉素摄取的染色体突变的大肠杆菌菌株的活性。
Antimicrob Agents Chemother. 2017 Dec 21;62(1). doi: 10.1128/AAC.01899-17. Print 2018 Jan.
10
Mutations of the Transporter Proteins GlpT and UhpT Confer Fosfomycin Resistance in .转运蛋白GlpT和UhpT的突变赋予了……对磷霉素的抗性
Front Microbiol. 2017 May 19;8:914. doi: 10.3389/fmicb.2017.00914. eCollection 2017.